NOVARTIS AGNOVARTIS AGNOVARTIS AG

NOVARTIS AG

No trades
See on Supercharts

Price target

2043.580.00 0.00%
The 22 analysts offering 1 year price forecasts for NOVN/N have a max estimate of — and a min estimate of —.

Analyst rating

Based on 29 analysts giving stock ratings to NOVN/N in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

NOVN/N EPS for the last quarter is 29.83 MXN despite the estimation of 27.80 MXN. In the next quarter EPS is expected to reach 33.55 MXN. Track more of NOVARTIS AG financials and stay on top of what is up with the company.
In the next quarter NOVARTIS AG revenue is expected to reach ‪227.70 B‬ MXN. Check out NOVARTIS AG revenue and earnings and make informed decisions.
According to analysts, NOVN/N price target is 2043.58 MXN with a max estimate of 2439.76 MXN and a min estimate of 1544.45 MXN. Check if this forecast comes true in a year, meanwhile watch NOVARTIS AG stock price chart and keep track of the current situation with NOVN/N news and stock market news.
We've gathered opinions of 29 analysts rating NOVN/N stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.